Wells Fargo’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250
| Closed | -$2.36K | – | 6676 |
|
|
2025
Q1 | $2.36K | Hold |
250
| – | – | ﹤0.01% | 5667 |
|
|
2024
Q4 | $3.08K | Buy |
+250
| New | +$3.08K | ﹤0.01% | 5631 |
|
|
2024
Q3 | – | Hold |
0
| – | -$6 | – | 6304 |
|
|
2024
Q2 | – | Hold |
0
| – | -$8 | – | 6311 |
|
|
2024
Q1 | – | Hold |
0
| – | -$6 | – | 6927 |
|
|
2023
Q4 | – | Hold |
0
| – | -$5 | – | 7023 |
|
|
2023
Q3 | – | Hold |
0
| – | -$1 | – | 7100 |
|
|
2023
Q2 | – | Hold |
0
| – | -$1 | – | 7250 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7320 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7152 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 6395 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6560 |
|
|
2022
Q1 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6711 |
|
|
2021
Q4 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6695 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6651 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6573 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6521 |
|